BioLife Solutions Inc.

BLFS

BioLife Solutions Inc. (BLFS) is a provider of biopreservation tools and systems for the long-term storage of cells, tissues, and organs. The company develops and markets advanced cryopreservation media, controlled-rate thawing systems, and other bioprocessing products primarily serving the biopharmaceutical, cell and gene therapy, and regenerative medicine industries. BioLife Solutions aims to improve the safety and efficacy of cell-based therapies through its innovative preservation technology.

$29.15 -1.26 (-4.16%)
🚫 BioLife Solutions Inc. does not pay dividends

Company News

BioLife Solutions to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026
Benzinga • Prnewswire • April 23, 2026

BioLife Solutions, Inc. (NASDAQ: BLFS) announced it will release its first quarter 2026 financial results on May 7, 2026, followed by a conference call and live webcast at 4:30pm ET. Management will provide an overview of financial results and a general business update.

BioLife Solutions Wins INTERPHEX 2026 Biotech Innovation Award for CellSeal® CryoCase
Benzinga • Prnewswire • April 21, 2026

BioLife Solutions received the INTERPHEX 2026 Biotech Innovation Award for its CellSeal® CryoCase, a rigid cryogenic containment system designed for frozen biologic materials in cell and gene therapy manufacturing. The product addresses documented container failures in CGT manufacturing where flexible cryobags have been susceptible to stress fra...

BioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations
Benzinga • Prnewswire • February 26, 2026

BioLife Solutions reported strong 2025 results with 29% full-year revenue growth to $96.2 million and Q4 revenue of $24.8 million (up 20% YoY). The company achieved GAAP net income of $2.1 million in Q4 and adjusted EBITDA of $6.9 million (28% margin). For 2026, BioLife projects revenue growth of 17-20% to $112.5-115 million and expects full-year...

BioLife Solutions to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update on February 26, 2026
Benzinga • Prnewswire • February 17, 2026

BioLife Solutions (NASDAQ: BLFS) announced it will release its fourth quarter and full year 2025 financial results on February 26, 2026, followed by a conference call and webcast at 4:30pm ET. Management will provide an overview of financial results and a general business update.

BioLife Solutions Signs Multi-Year Supply Agreement with Qkine Limited to Expand its Product Portfolio into the Rapidly Growing Cytokines Market
Benzinga • Prnewswire • February 12, 2026

BioLife Solutions (NASDAQ: BLFS) has entered into a multi-year supply agreement with Qkine Limited to distribute cytokine and growth factor products for the cell and gene therapy market. The agreement grants BioLife exclusive worldwide distribution rights to specific Qkine products and includes collaboration on product development using BioLife's...

Related Companies